The Ministry of industry and trade of the Russian Federation
FSI «SID & GP»
+7 (495) 676-4360 109044, Moscow, Lavrov lane., 6

History

   
1973
The department of technology of endocrine drugs of the All-Soviet-Union Scientific Research Institute of Automation (VNIIA) and Moscow Drug Products Plant No. 1 served as the basis for creating the All-Soviet-Union Research and Development Institute of Blood Substitutes and Hormonal Drugs Technologies (VNIITKGP).
1993
The VNIITKGP was renamed to become FSI “State Institute of Blood Substitutes and Medical Preparations” (FSI “SIBS & MP”). During the 1990s, which were the difficult time for the whole country, the Institute was the only one of the 7 specialized scientific institutions in the industry to preserve its structure and drugs development functions.
2000
The Federal State Institution “State Institute of Blood Substitutes and Medical Preparations” was transferred to the Ministry of Industry, Science and Technologies of the Russian Federation.
Since mid
2000
The Institute is actively cooperating with pharmaceutical enterprises and drugs development companies. During the last 10 years, the Institute created 38 drug products (blood substitutes, organotherapeutical preparations, genetically engineered insulins, etc.), the majority of which were put into manufacturing at the major pharmaceutical enterprises of the country.
2008
FSI “State Institute of Blood Substitutes and Medical Preparations” was transferred to the Ministry of Industry and Trade of the Russian Federation.
2014
The Institute was renamed to become the Federal State Institution “State Institute of Drugs and Good Practices” (FSI “SID & GP”). FSI “SID & GP” was accredited as the expert organization engaged in the license control of pharmaceutical enterprises located in the Russian Federation, in the composition of the commission of the Minpromtorg of Russia.
2015
FSI “SID & GP” was authorized to inspect the manufacturers of human drugs effecting the manufacturing outside the Russian Federation to check the manufacturers’ compliance with the GMP Rules with the purpose of issuing the certificates of the drugs manufacturers’ compliance with Good Manufacturing Practice.
2016
Beginning of the inspection of the manufacturers of human drugs effecting the manufacturing outside the Russian Federation and supplying their products to the pharmaceutical market of Russia for compliance with Good Manufacturing Practice. The GMP I all-Russian conference with the participation of foreign specialists was carried out, bringing together the pharmaceutical industry experts and the representatives of the regulatory bodies and specialized associations.